Market Overview:
The global recombinant human albumin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for recombinant human albumin from various applications such as cell culture media, medical supplements, and others. Additionally, the increasing awareness about the benefits of using recombinant human albumin is also contributing to the growth of this market.
Product Definition:
A recombinant human albumin is a protein produced through genetic engineering techniques. This protein is identical to the albumin found in human blood and can be used as a treatment for various medical conditions. Albumin helps to maintain fluid balance in the body, transports nutrients, and removes waste products. Recombinant human albumin is used to treat shock, burns, surgery, and other medical conditions.
OsrHSA:
OsrHSA is a human recombinant albumin that has been characterized as an immunoglobulin with high specificity for the H-2 class of histocompatibility antigen. It is biosimilar to native human serum albumin and differs from it only in its higher concentration and shorter length of amino acids. OsrHSA has about 50% more amino acids than regular Human Serum Albumin (HSA).
ScrHSA:
ScrHSA is a human-specific version of the heat shock protein. It has been studied extensively for its use in improving the quality and yield of recombinant human albumin (rhAlb). ScrHSA helps to increase both, i.e., production as well as purity levels, by acting as an efficient thermal stabilizer during purification and recovery process.
Application Insights:
Medical supplements emerged as the leading application segment and accounted for a revenue share of over 70.0% in 2017. The growing geriatric population, coupled with rising incidences of chronic diseases such as heart diseases, cancer and diabetes across the globe is expected to create huge demand for recombinant human albumin (rHAA) medical supplements during the forecast period.
Cell culture media was the second-largest application segment in 2017 owing to increasing utilization of rHAA in cell cultivation due to its ability to support cell growth at optimal temperatures and maintain cellular structures/functions intact. It is also used during culturing procedures such as seeding, tissue expansion or spheroids formation that are specific to various research fields including stem cells & regenerative medicine, drug discovery & development and immunology among others.
Regional Analysis:
North America was the largest regional market in 2017 owing to high awareness levels regarding blood donation and adoption of a healthy lifestyle. Increasing prevalence of chronic diseases such as cancer, diabetes, & cardiovascular disorders is expected to boost the demand for albumin-based products over the forecast period.
Asia Pacific is estimated to be fastest-growing region during the forecast years on account of rising healthcare expenditure and increasing disposable income levels in emerging countries such as China & India. Furthermore, growing interest from companies for commercializing novel protein therapeutics will drive growth further.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases (NCDs) are responsible for over 63% of all deaths worldwide. Albumin plays a crucial role in managing various chronic conditions such as renal failure, liver cirrhosis, and burns. Thus, the increasing prevalence of chronic diseases is expected to drive the demand for recombinant human albumin in the coming years.
- Growing awareness about therapeutic benefits: There is growing awareness among healthcare professionals and patients about the therapeutic benefits offered by recombinant human albumin products. This has led to an increase in their use for various indications such as shock, sepsis, and trauma-related bleeding disorders. The rising demand for recombinant human albumin products is likely to boost market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Recombinant Human Albumin Market Research Report
By Type
OsrHSA, ScrHSA
By Application
Cell Culture Media, Medical Supplements, Others
By Companies
Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Recombinant Human Albumin Market Report Segments:
The global Recombinant Human Albumin market is segmented on the basis of:
Types
OsrHSA, ScrHSA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell Culture Media, Medical Supplements, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Albumedix
- Merck
- Ventria (InVitria)
- NCPC
- Oryzogen
- HiMedia
Highlights of The Recombinant Human Albumin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- OsrHSA
- ScrHSA
- By Application:
- Cell Culture Media
- Medical Supplements
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Recombinant Human Albumin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Recombinant human albumin is a protein made from recombinant DNA technology. It is a type of serum protein that helps to transport and carry oxygen and other nutrients throughout the body.
Some of the major companies in the recombinant human albumin market are Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia.
The recombinant human albumin market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Recombinant Human Albumin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Recombinant Human Albumin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Recombinant Human Albumin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Recombinant Human Albumin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Recombinant Human Albumin Market Size & Forecast, 2020-2028
4.5.1 Recombinant Human Albumin Market Size and Y-o-Y Growth
4.5.2 Recombinant Human Albumin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 OsrHSA
5.2.2 ScrHSA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cell Culture Media
6.2.2 Medical Supplements
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Recombinant Human Albumin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Recombinant Human Albumin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 OsrHSA
9.6.2 ScrHSA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cell Culture Media
9.10.2 Medical Supplements
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 OsrHSA
10.6.2 ScrHSA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cell Culture Media
10.10.2 Medical Supplements
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 OsrHSA
11.6.2 ScrHSA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cell Culture Media
11.10.2 Medical Supplements
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 OsrHSA
12.6.2 ScrHSA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cell Culture Media
12.10.2 Medical Supplements
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 OsrHSA
13.6.2 ScrHSA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cell Culture Media
13.10.2 Medical Supplements
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Recombinant Human Albumin Market: Competitive Dashboard
14.2 Global Recombinant Human Albumin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Albumedix
14.3.2 Merck
14.3.3 Ventria (InVitria)
14.3.4 NCPC
14.3.5 Oryzogen
14.3.6 HiMedia
